Dr. Carmine Gentile Joins the 4th Edition of REGEMAT 3D’s Course on 3D Bioprinting& Cell Culture

Granada, Spain – May 8, 2025 – REGEMAT 3D is proud to announce that Dr. Carmine
Gentile, a global reference in cardiac tissue engineering and 3D bioprinting, will join the
4th Edition of the 3D Bioprinting & Cell Culture Course, taking place from July 7–11,
2025, in Granada, Spain.

About Dr. Carmine Gentile:
▪ Current Role: Leader of the Cardiovascular Regeneration Group at the University of
Technology Sydney (UTS) and the Heart Research Institute (HRI).
▪ Academic Background: PharmD and PhD in Biomedical Sciences (Cardiovascular);
research experience in Italy, the USA, and Australia.
▪ Expertise: 3D bioprinting, stem cells, cardiac regeneration, and “mini-heart” disease
modeling.
▪ Career Highlights: Former Visiting Fellow at Harvard Medical School; recipient of
numerous fellowships and awards.

More on his work | Research overview
His talk will enrich the course by offering first-hand insights into the development of
engineered cardiac tissues and the future of regenerative cardiovascular medicine.

Course Details
▪ Dates: July 7–11, 2025
▪ Location: REGEMAT 3D HQ – Granada, Spain
▪ Duration: 35 hours of hands-on training
▪ Topics: 3D bioprinting, bioinks, bioreactors, advanced cell culture, and more
Register now

Contact: info@regemat3d.com
Don’t miss this unique opportunity to learn directly from Dr. Gentile and other global leaders
in the field of biofabrication.